2021
DOI: 10.1016/j.aace.2021.01.006
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Severe Hypertriglyceridemia During Pregnancy With High Doses of Omega-3 Fatty Acid and Plasmapheresis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 22 publications
0
7
0
Order By: Relevance
“…FFP as fluid replacement successfully reduced lipid levels without complications and the symptoms of patients in the acute phase of the disease (8). This is because FFP may provide circulating TG hydrolysis by reducing inflammatory cytokines and replacing the deficiency of lipoprotein lipase or apolipoprotein (9). Finally, in this case, we recommend having close monitoring throughout the time the patient receives the infusion of insulin and FFP.…”
Section: Discussionmentioning
confidence: 94%
“…FFP as fluid replacement successfully reduced lipid levels without complications and the symptoms of patients in the acute phase of the disease (8). This is because FFP may provide circulating TG hydrolysis by reducing inflammatory cytokines and replacing the deficiency of lipoprotein lipase or apolipoprotein (9). Finally, in this case, we recommend having close monitoring throughout the time the patient receives the infusion of insulin and FFP.…”
Section: Discussionmentioning
confidence: 94%
“…[6] The capillary endothelium is normally rich in ARA, suggesting that angiogenesis would be enhanced in the presence of ample ARA and inhibited when ARA is limiting. [13] EPA/DHA doses higher than 20 g/d have been used on a sustained basis (months to years) in humans for the treatment of traumatic brain injury, [14] 12 g/d to 15 g/d in hypertriglyceridemia [15] or hypertensive patients, [16] and in at least one pregnant woman who gave birth successfully, [17] and all doses were well tolerated. Enhanced bleeding times might be expected based on observations in individuals with high circulating EPA levels, though a recent metaanalysis showed mild effects up to 4 g/d.…”
Section: Discussionmentioning
confidence: 99%
“…It should be noted that dyslipidemia during pregnancy should be carefully assessed not only for its acute complications but also to determine the long-term disease risk and risk of death of the fetus. Previously, the application of Beite drugs, heparin, and plasma exchange was reported to rapidly reduce blood lipids in pregnant women ( 28 , 29 ). However, few studies have addressed the management of HTG during pregnancy through medical nutrition therapy ( 30 , 31 ).…”
Section: Discussionmentioning
confidence: 99%